Bupa Singapore Holdings Pte. Ltd; and Bupa Investments Overseas Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The two promoter entities of Niva Bupa Health Insurance — Bupa Singapore Holdings Pte Ltd and Bupa Investments Overseas Limited — have filed a routine annual declaration with NSE and BSE as required under SEBI's Takeover Regulations. Both promoters have confirmed that they did not create any encumbrance (pledge, lien, or charge) on the company's shares, directly or indirectly, during the entire financial year 2024-25. The disclosure was signed by Penelope Ruth Dudley, Director of Bupa Singapore Holdings, and the same declaration was submitted by Bupa Investments Overseas Limited from London. This is a compliance filing required every financial year, and the contents are confirmatory rather than event-driven.
This is a neutral, routine regulatory filing with no material impact on the stock. It simply reassures investors that promoters have not pledged or encumbered their holdings during FY25, which removes a potential overhang concern. No change in promoter shareholding is implied.